featured
Isatuximab Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients With Renal Impairment
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Leukemia
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Isatuximab Plus Pomalidomide and Dexamethasone in Relapsed/Refractory Multiple Myeloma Patients With Renal Impairment: ICARIA-MM Subgroup Analysis
Leukemia 2020 May 23;[EPub Ahead of Print], MA Dimopoulos, X Leleu, P Moreau, PG Richardson, AM Liberati, SJ Harrison, H Miles Prince, EM Ocio, S Assadourian, F Campana, L Malinge, D Sémiond, H van de Velde, K YongFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.